Fundraising Fox
🦊/Companies
Sign in

Tenon Medical

NASDAQ: TNON

Los Gatos, US · Delaware corporation · 1 known investors

Find your way into Tenon Medical

243 people in our graph share verified history with the Tenon Medical team — schools, employers, funds. One of them is your warm intro.

Will McGinnisunlockedknows Wyatt D. Geist · together at Auburn University
×7knows the team · via University of Miami
×4knows the team · via Auburn University

Tenon Medical develops the Catamaran SI Joint Fusion System, a titanium implant and surgical device that fuses the sacroiliac joint through a less invasive inferior-posterior approach for conditions such as sacroiliac joint disruptions and degenerative sacroiliitis. The company serves surgeons treating SI joint pain and is a medical device manufacturer.

HealthtechMedical Devices

Founders & leadership

RGRichard Ginn
Richard GinninChief Technology OfficerCo-founder and CTO of Tenon Medical, Richard Ginn has over 30 years of experience in the medical device industry and holds more than 300 patents related to medical device design and development.
KWKevin Williamson
Kevin WilliamsoninChief Financial Officer
SFSteven Foster
Steven FosterinChief Executive Officer and President
SV
Steven Van DickExecutive
WD
Wyatt D. GeistinChief Innovation OfficerWyatt D. Geist is Chief Innovation Officer at Tenon Medical. He has experience across company formation, capital raising, product development, marketing, and sales in medical device and technology ventures.
NA
Nathaniel A. GraweyChief Commercial Officer
JH
James HuieNamed on SEC filing
KM
Kal MentakNamed on SEC filing

Board

RFRichard Ferrari
Richard FerrariExecutive Chairman of the Board
RW
Robert WeigleBoard director
SHStephen Hochschuler
Stephen HochschulerBoard director
IHIvan Howard
Ivan HowardBoard director

Investors · 1

Zühlke VenturesZurich · $165K – $275K

Reported raises · per SEC filings

Form D private placements

$34.9M disclosed across 10 rounds · 2021–2026

▶$4.3MraisedSep 2026 · 1 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Steven M. FosterExecutive Officer, Director
  • Richard GinnExecutive Officer, Director
  • Kevin WilliamsonExecutive Officer
  • Wyatt D. GeistExecutive Officer
  • Nathaniel A. GraweyExecutive Officer
  • Richard FerrariDirector
  • Ivan HowardDirector
  • Kristine M. JacquesDirector
  • Robert K. WeigleDirector
  • Stephen H. Hochschuler, M.D.Director
Offering amount
$4.3M
Amount sold
$4.3M
Sales commissions
$201.1K
Placement agents
WallachBeth Capital LLC
First sale
Sep 2026
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$3MraisedSep 2026 · 1 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Ivan HowardDirector
  • Kristine M. JacquesDirector
  • Robert K. WeigleDirector
  • Steven H. HochschulerDirector
  • Steven M. FosterExecutive Officer, Director
  • Richard GinnExecutive Officer, Director
  • Kevin WilliamsonExecutive Officer
  • Wyatt D. GeistExecutive Officer
  • Nathaniel A. GraweyExecutive Officer
  • Richard FerrariDirector
Offering amount
$3M
Amount sold
$3M
Sales commissions
$275K
Placement agents
WallachBeth Capital LLC
First sale
Aug 2026
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$4.3MraisedMar 2026 · 6 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Stephen H. Hochschuler, M.D.Director
  • Richard GinnExecutive Officer, Director
  • Kristine JacquesDirector
  • Kevin WilliamsonExecutive Officer
  • Ivan HowardDirector
  • Robert K. WeigleDirector
  • Steven M. FosterExecutive Officer, Director
  • Richard FerrariDirector
Offering amount
$4.3M
Amount sold
$4.3M
Placement agents
WallachBeth Capital, LLC.
First sale
Mar 2026
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2.9MraisedNov 2025 · 29 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Richard GinnExecutive Officer, Director
  • Ivan HowardDirector
  • Nathaniel A. GraweyExecutive Officer
  • Robert K. WeigleDirector
  • Richard FerrariDirector
  • Kristine M. JacquesDirector
  • Wyatt D. GeistExecutive Officer
  • Kevin WilliamsonExecutive Officer
  • Steven M. FosterExecutive Officer, Director
  • Stephen H. Hochschuler, M.D.Director
Offering amount
$2.9M
Amount sold
$2.9M
First sale
Nov 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$4.6MraisedApr 2025 · 1 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Stephen HochschulerDirector
  • Richard FerrariExecutive Officer
  • Robert WeigleDirector
  • Steven FosterExecutive Officer
  • Ivan HowardDirector
  • Richard GinnExecutive Officer, Director
  • Kevin WilliamsonExecutive Officer
Offering amount
$4.6M
Amount sold
$4.6M
Placement agents
A.G.P./Alliance Global Partners
First sale
Mar 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.5MraisedApr 2025 · 1 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Richard GinnExecutive Officer, Director
  • Ivan HowardDirector
  • Robert WeigleDirector
  • Stephen HochschulerDirector
  • Richard FerrariExecutive Officer
  • Kevin WilliamsonExecutive Officer
  • Steven FosterExecutive Officer, Director
Offering amount
$1.5M
Amount sold
$1.5M
Placement agents
A.G.P./Alliance Global Partners
First sale
Mar 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2.5MraisedApr 2025 · 1 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Kevin WilliamsonExecutive Officer
  • Robert WeigleDirector
  • Richard FerrariExecutive Officer
  • Steven FosterExecutive Officer, Director
  • Stephen HochschulerDirector
  • Richard GinnExecutive Officer, Director
  • Ivan HowardDirector
Offering amount
$2.5M
Amount sold
$2.5M
Placement agents
A.G.P./Alliance Global Partners
First sale
Mar 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2.6MraisedFeb 2024 · 46 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • STEPHEN HOCHSCHULERDirector
  • STEVEN FOSTERExecutive Officer, Director
  • ROBERT WEIGLEDirector
  • IVAN HOWARDDirector
  • RICHARD GINNExecutive Officer, Director
  • RICHARD FERRARIDirector
  • STEVE VAN DICKExecutive Officer
Offering amount
$6M
Amount sold
$2.6M
First sale
Feb 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Valuation · disclosed

Disclosed events
$6.4Mvaluation at IPOSep 2024 · $3.68/share · 424B4
filing ↗

Source: SEC prospectus filings, and round valuations the company or its investors disclosed — follow each entry's link for the claim.

Founder mafia

2 people who came through Tenon Medical went on to found or lead other companies.

Geoff DillonPresident/CEOFounded SellhoundWyatt D. GeistChief Innovation OfficerFounded Integrity Implants

Competitors · 1

by search overlap
PainTEQ53 shared keywordsPainTEQ develops medical devices and implants for sacroiliac joint dysfunction, offering solutions ranging from biologicalbone allografts to titanium implants as alternatives to injections or fusion surgery. The company focuses exclusively on sacroiliac joint treatment for patients and physicians.

Companies competing with Tenon Medical for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

Tenon Medical back in Nasdaq bid-price compliance | TNON 8-K Filingstocktitan.net · Aug 2026Tenon Medical regains Nasdaq minimum bid price compliance By Investing.cominvesting.com · Aug 2026TNON Stock Whipsaws As Revenue Soars But Losses Deepentimothysykes.com · Aug 2026Tenon Medical Reports Second Quarter 2026 Financial Results - BioSpacebiospace.com · Aug 2026

Frequently asked questions

What does Tenon Medical do?
Tenon Medical develops the Catamaran SI Joint Fusion System, a titanium implant and surgical device that fuses the sacroiliac joint through a less invasive inferior-posterior approach for conditions such as sacroiliac joint disruptions and degenerative sacroiliitis. The company serves surgeons treating SI joint pain and is a medical device manufacturer.
Who founded Tenon Medical?
Tenon Medical was founded by Richard Ginn.
Who are Tenon Medical's investors?
Tenon Medical's investors include Zühlke Ventures.
How much funding has Tenon Medical raised?
Tenon Medical has disclosed $34.9M raised across 10 rounds.
Where is Tenon Medical headquartered?
Tenon Medical is headquartered in Los Gatos, US.